Gland Pharma

quarterly
yearly
ParticularsDec '24Mar '25Jun '25Sep '25Dec '25
Revenue1,4431,4691,5631,5711,759
Expenses1,1431,1811,2501,2871,372
EBITDA418.45391.54425.29398.05498.05
EBIT322.12295.78324.24291.74366.06
Profit Before Tax299.30288.33312.74283.91362.13
Net Profit204.69186.54215.48183.68261.48
Financial Ratios
Operating Profit Margin30.23%27.48%28.25%26.77%27.94%
Net Profit Margin14.79%13.09%14.31%12.35%16.43%
Earning Per Share (Diluted)12.4211.3213.0811.1515.87
Dividends Per Share0.000.000.000.000.00